2016
DOI: 10.1016/j.molimm.2015.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 120 publications
1
25
0
1
Order By: Relevance
“…Most studies show that almost 90% of CVID patients have normal B-cell counts, [35,36], indicating that the major defect is likely related to alterations of the terminal stages of B-cell differentiation. Furthermore, several groups, including our own, have shown that disturbed B-cell subsets could result from an increase of terminal B-cell apoptosis [37,38]. Impaired antibody production despite normal B-cell counts also suggests a defect in the differentiation of B cells into memory and plasma cells in many CVID patients [35].…”
Section: B-cell Subsetsmentioning
confidence: 86%
“…Most studies show that almost 90% of CVID patients have normal B-cell counts, [35,36], indicating that the major defect is likely related to alterations of the terminal stages of B-cell differentiation. Furthermore, several groups, including our own, have shown that disturbed B-cell subsets could result from an increase of terminal B-cell apoptosis [37,38]. Impaired antibody production despite normal B-cell counts also suggests a defect in the differentiation of B cells into memory and plasma cells in many CVID patients [35].…”
Section: B-cell Subsetsmentioning
confidence: 86%
“…[58] T and B cells have a higher rate of spontaneous and induced apoptosis in patients with CVID, and Yazdani and colleagues have recently suggested that the same mechanism may be present in those with SIgAD, although this mechanism has yet to be confirmed in individuals with SIgAD. [59] Additionally, SIgAD has been transferred between patients via bone marrow grafting, which further suggests a defect in immune cells. [46] The monogenic hypothesis suggests that certain as-yet undiscovered monogenic mutations predispose both to the development of SIgAD and autoimmune conditions.…”
Section: Mechanisms Of Autoimmunity In Iga Deficiencymentioning
confidence: 99%
“…In this regard, Hammarström and colleagues [45] reported that SIgAD patients lack surface IgA B cells, and the combination of IL-4, IL-21, and the anti-CD40 monoclonal antibody can prevent apoptosis of these cells in SIgAD patients, and result in reconstitution of IgA secretion. A notable point is that in spite of the intact genes and molecular mechanisms of IgA recombination, and in addition to the reports that show low surface IgA-positive B cells in patients with SIgAD, the existence of a defect in the long-term survival of IgA secreting cells and memory B cells should be considered [14]. …”
Section: Pathogenesis Of Sigadmentioning
confidence: 99%